Complete Filing Data
Guardant Health, Inc. reported Stockholders Equity of -$99.31 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Guardant Health, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$416.3M | -$436.4M | -$479.4M | -$654.6M | -$384.8M | -$246.3M | -$75.7M | -$85.1M | -$83.2M | -$46.1M |
| Other Comprehensive Income Loss Net Of Tax | $349.0K | -$1.5M | $15.8M | -$14.8M | -$7.5M | $1.6M | $1.2M | $449.0K | -$446.0K | -$76.0K |
| Selling And Marketing Expense | $494.7M | $364.9M | $295.2M | $299.8M | $191.9M | $106.5M | $78.3M | $53.5M | $32.5M | $26.2M |
| Revenues | $982.0M | $739.0M | $563.9M | $449.5M | $373.7M | $286.7M | $214.4M | $90.6M | $49.8M | $25.2M |
| Research And Development Expense | $364.2M | $347.8M | $367.2M | $373.8M | $263.2M | $149.9M | $86.3M | $50.7M | $25.6M | $10.9M |
| Other Nonoperating Income Expense | -$10.5M | -$42.6M | $53.2M | -$12.8M | $25.2M | $3.6M | $88.0K | $4.7M | -$1.1M | -$1.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$142.0K | $244.0K | $16.8M | -$13.2M | -$5.8M | $1.1M | $1.1M | $449.0K | -$446.0K | -$76.0K |
| Operating Income Loss | -$437.2M | -$443.6M | -$564.7M | -$544.4M | -$411.0M | -$255.0M | -$82.4M | -$92.9M | -$76.6M | -$43.8M |
| Income Tax Expense Benefit | -$1.3M | $1.3M | $685.0K | $1.1M | $300.0K | $379.0K | -$1.9M | $38.0K | $7.0K | $6.0K |
| General And Administrative Expense | $211.4M | $180.1M | $155.8M | $164.0M | $206.6M | $192.8M | $61.4M | $36.2M | $36.8M | $9.9M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $491.0K | -$1.8M | -$911.0K | -$1.6M | -$1.7M | $455.0K | $84.0K | $0.00 | $0.00 | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$437.9M | -$463.6M | -$669.3M | -$392.2M | -$244.7M | -$66.7M | -$83.8M | -$83.7M | -$46.2M | |
| Comprehensive Income Net Of Tax | -$415.9M | -$437.9M | -$463.6M | -$669.3M | -$413.1M | -$252.2M | -$74.5M | -$84.6M | -$83.7M | -$46.2M |
| Interest Expense | $2.6M | $2.6M | $2.6M | $4.8M | $1.2M | $1.3M | $2.7M | $3.0M | ||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest | $0.00 | $0.00 | $20.9M | $7.5M | $7.8M | $800.0K | $0.00 | $0.00 | ||
| Net Income Loss Available To Common Stockholders Basic | -$479.4M | -$654.6M | -$405.7M | -$253.8M | -$75.7M | -$85.1M | -$89.0M | -$46.1M | ||
| Net Income Loss Attributable To Redeemable Noncontrolling Interest | $0.00 | $0.00 | $20.9M | $7.5M | $7.8M | $800.0K | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$417.5M | -$435.1M | -$478.8M | -$653.4M | -$384.5M | -$245.9M | -$69.7M | |||
| Non Cash Operating Lease Costs | $33.6M | $31.1M | $29.7M | $28.6M | $24.7M | $5.6M | $4.4M | $0.00 | ||
| Cost Of Goods And Services Sold | $349.0M | $289.8M | $227.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$92.7M | -$99.9M | -$95.2M | -$107.8M | -$102.6M | -$115.0M | -$86.1M | -$72.8M | -$133.5M | -$162.0M | -$229.4M | -$123.2M | -$107.5M | -$97.6M | -$107.4M | -$71.7M | -$49.7M | -$31.8M | -$13.1M | -$11.3M | -$21.4M | -$24.5M | -$21.6M | -$13.8M | -$28.6M |
| Other Comprehensive Income Loss Net Of Tax | -$537.0K | $935.0K | $543.0K | $2.4M | -$841.0K | -$1.1M | $2.8M | $3.7M | $7.4M | -$2.6M | -$5.9M | -$13.6M | -$626.0K | -$871.0K | -$1.8M | -$1.5M | -$2.3M | $6.6M | -$235.0K | $1.0M | $416.0K | $161.0K | $138.0K | -$298.0K | $6.0K |
| Selling And Marketing Expense | $127.4M | $119.6M | $104.3M | $97.9M | $81.9M | $80.4M | $68.9M | $71.0M | $76.1M | $80.4M | $73.6M | $64.4M | $50.2M | $47.7M | $34.3M | $25.1M | $25.0M | $25.1M | $18.8M | $19.4M | $17.8M | $13.5M | $11.6M | $11.3M | $7.8M |
| Revenues | $265.2M | $232.1M | $203.5M | $191.5M | $177.2M | $168.5M | $143.0M | $137.2M | $128.7M | $117.4M | $109.1M | $96.1M | $94.8M | $92.1M | $78.7M | $74.6M | $66.3M | $67.5M | $60.8M | $54.0M | $36.7M | $21.7M | $19.4M | $16.7M | $11.1M |
| Research And Development Expense | $90.0M | $87.4M | $88.5M | $87.3M | $83.1M | $83.8M | $93.9M | $90.4M | $93.1M | $100.0M | $85.5M | $81.8M | $71.0M | $63.7M | $55.5M | $36.2M | $36.3M | $37.0M | $24.6M | $19.5M | $16.3M | $14.3M | $11.6M | $8.3M | $7.2M |
| Other Nonoperating Income Expense | -$48.0K | -$25.0K | $7.9M | -$3.0M | -$15.1M | -$29.1M | $16.9M | $41.3M | -$1.7M | -$18.4M | $378.0K | -$48.0K | -$187.0K | -$243.0K | -$290.0K | $345.0K | $2.3M | -$209.0K | $179.0K | -$51.0K | $147.0K | $43.0K | $395.0K | $4.1M | -$266.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$4.0K | -$2.0K | -$230.0K | $456.0K | -$4.0K | $14.0K | $3.3M | $4.9M | $7.5M | -$2.1M | -$4.5M | -$12.8M | -$513.0K | -$878.0K | -$706.0K | -$1.7M | -$2.3M | $6.6M | -$282.0K | $852.0K | $485.0K | $188.0K | $138.0K | -$298.0K | $6.0K |
| Operating Income Loss | -$99.0M | -$106.4M | -$111.0M | -$117.3M | -$100.6M | -$99.7M | -$113.5M | -$119.6M | -$134.1M | -$144.6M | -$130.3M | -$123.3M | -$107.3M | -$97.6M | -$107.9M | -$74.3M | -$54.6M | -$34.9M | -$17.5M | -$15.3M | -$23.7M | -$24.2M | -$22.7M | -$18.6M | -$28.7M |
| Income Tax Expense Benefit | $136.0K | $38.0K | $290.0K | $30.0K | $133.0K | $405.0K | $490.0K | $496.0K | $240.0K | $115.0K | $446.0K | -$24.0K | $96.0K | $83.0K | $110.0K | $68.0K | $34.0K | $14.0K | -$202.0K | -$1.2M | $26.0K | $0.00 | $3.0K | $0.00 | $0.00 |
| General And Administrative Expense | $53.3M | $50.3M | $47.0M | $49.1M | $40.5M | $38.7M | $36.2M | $41.5M | $40.4M | $41.1M | $43.7M | $41.3M | $50.1M | $48.4M | $67.9M | $66.3M | $37.2M | $19.8M | $16.4M | $13.4M | $12.7M | $8.1M | $9.0M | $6.5M | $16.1M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$533.0K | $937.0K | $773.0K | $1.9M | -$837.0K | -$1.1M | -$526.0K | -$1.3M | -$163.0K | -$529.0K | -$1.4M | -$792.0K | -$113.0K | $7.0K | -$1.1M | $191.0K | $25.0K | $23.0K | $47.0K | $159.0K | -$69.0K | -$27.0K | $0.00 | $0.00 | $0.00 |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$94.6M | -$105.4M | -$103.5M | -$116.1M | -$83.3M | -$69.1M | -$126.2M | -$164.6M | -$235.4M | -$136.8M | -$108.2M | -$98.4M | -$109.2M | -$73.2M | -$52.1M | -$25.2M | -$13.3M | -$10.3M | -$20.9M | -$23.3M | -$21.5M | -$14.1M | -$28.6M | ||
| Comprehensive Income Net Of Tax | -$93.3M | -$99.0M | -$105.4M | -$103.5M | -$126.2M | -$164.6M | -$235.4M | -$136.8M | -$108.2M | -$98.4M | -$111.5M | -$79.2M | -$57.0M | -$21.1M | -$13.0M | -$10.6M | -$25.6M | -$24.3M | -$21.5M | -$14.1M | -$28.6M | ||||
| Interest Expense | $645.0K | $644.0K | $645.0K | $644.0K | $644.0K | $645.0K | $644.0K | $644.0K | $644.0K | $646.0K | $8.0K | $10.0K | $12.0K | $280.0K | $287.0K | $293.0K | $304.0K | $317.0K | $331.0K | $303.0K | |||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.3M | $6.0M | $4.9M | -$4.1M | -$300.0K | $300.0K | $4.7M | $950.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Net Income Loss Available To Common Stockholders Basic | -$162.0M | -$229.4M | -$123.2M | -$107.5M | -$97.6M | -$109.7M | -$77.7M | -$54.6M | -$27.7M | -$12.8M | -$11.6M | -$26.1M | -$24.5M | -$21.6M | -$13.8M | -$33.3M | |||||||||
| Net Income Loss Attributable To Redeemable Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.3M | $6.0M | $4.9M | -$4.1M | -$300.0K | $300.0K | $4.7M | $950.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$92.6M | -$99.9M | -$94.9M | -$107.7M | -$102.5M | -$114.6M | -$85.6M | -$72.3M | -$133.3M | -$161.9M | -$229.0M | -$123.3M | -$107.4M | -$97.5M | -$107.2M | -$71.6M | |||||||||
| Non Cash Operating Lease Costs | $7.9M | $7.6M | $7.3M | $6.9M | $3.9M | $1.5M | |||||||||||||||||||
| Cost Of Goods And Services Sold | $93.6M | $81.2M | $74.7M | $74.5M | $72.4M | $65.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$99.3M | -$139.6M | $158.7M | $60.2M | $645.0M | $1.30B | $798.4M | $483.2M | $308.6M | $79.7M | $83.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $489.4M | $629.8M | $1.13B | $141.9M | $492.3M | $833.0M | $143.2M | $140.5M | $72.6M | $33.6M | $4.3M |
| Cash And Cash Equivalents At Carrying Value | $378.2M | $525.5M | $1.13B | $141.6M | $492.2M | $833.0M | $143.2M | $140.5M | $72.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$140.3M | -$503.9M | $991.7M | -$350.3M | -$340.7M | $689.7M | $2.7M | $67.9M | $39.0M | ||
| Accretion Amortization Of Discounts And Premiums Investments | $5.9M | $6.8M | $13.6M | -$4.6M | -$12.8M | -$4.0M | $2.3M | $412.0K | -$359.0K | -$287.0K | |
| Retained Earnings Accumulated Deficit | -$2.99B | -$2.58B | -$2.14B | -$1.66B | -$1.01B | -$606.6M | -$352.8M | -$280.8M | -$195.7M | ||
| Property Plant And Equipment Net | $145.9M | $136.8M | $145.1M | $167.9M | $124.5M | $62.8M | $43.7M | $31.0M | $16.0M | ||
| Prepaid Expense And Other Assets Current | $40.7M | $33.8M | $27.7M | $31.5M | $53.1M | $17.5M | $11.4M | $5.2M | $1.5M | ||
| Other Liabilities Noncurrent | $127.8M | $92.8M | $96.0M | $9.2M | $3.9M | $1.5M | $1.7M | $325.0K | $0.00 | ||
| Other Assets Noncurrent | $28.5M | $37.2M | $124.2M | $61.5M | $60.9M | $17.3M | $4.9M | $2.0M | $2.0M | ||
| Liabilities Current | $302.7M | $225.6M | $205.9M | $193.2M | $194.7M | $66.8M | $72.7M | $46.9M | $19.6M | ||
| Liabilities And Stockholders Equity | $2.01B | $1.49B | $1.79B | $1.61B | $2.20B | $2.27B | $962.5M | $587.4M | $342.9M | ||
| Liabilities | $2.11B | $1.63B | $1.63B | $1.55B | $1.56B | $916.2M | $114.5M | $62.5M | $34.3M | ||
| Inventory Net | $85.9M | $71.1M | $61.9M | $51.6M | $30.7M | $22.7M | $15.2M | $9.1M | $7.3M | ||
| Common Stock Value Outstanding | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0.00 | ||
| Assets Current | $1.47B | $1.06B | $1.35B | $1.19B | $1.11B | $1.89B | $597.4M | $469.0M | $242.9M | ||
| Assets | $2.01B | $1.49B | $1.79B | $1.61B | $2.20B | $2.27B | $962.5M | $587.4M | $342.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.9M | -$5.2M | -$3.7M | -$19.5M | -$4.8M | $2.7M | $1.1M | -$83.0K | -$532.0K | ||
| Accounts Receivable Net Current | $137.8M | $110.3M | $88.8M | $97.3M | $97.7M | $53.3M | $48.0M | $35.7M | $12.8M | ||
| Intangible Assets Net Excluding Goodwill | $25.9M | $6.8M | $9.0M | $11.7M | $14.2M | $16.2M | $8.5M | $0.00 | |||
| Goodwill | $77.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $0.00 | |||
| Operating Lease Right Of Use Asset | $158.8M | $142.3M | $157.6M | $174.0M | $189.4M | $37.3M | $29.1M | $14.5M | |||
| Accounts Payable Current | $54.4M | $38.6M | $51.7M | $7.3M | $16.2M | $10.6M | $5.0M | ||||
| Operating Lease Liability Noncurrent | $178.5M | $164.3M | $185.8M | $210.0M | $226.1M | $41.6M | $33.3M | ||||
| Accrued Liabilities Current | $77.9M | $68.3M | $22.6M | $25.7M | $7.2M | $6.4M | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $41.2M | $7.9M | $5.0M | $4.1M | $171.4M | $13.1M | $16.7M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$354.5M | -$305.5M | -$250.8M | -$60.1M | -$1.6M | $68.3M | $228.3M | $292.7M | -$44.6M | $166.7M | $319.1M | $533.0M | $709.4M | $788.1M | $847.0M | $1.09B | $1.11B | $785.1M | $815.4M | $815.5M | $468.1M | $255.2M | $276.8M | $296.8M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $689.5M | $735.5M | $803.9M | $688.4M | $1.04B | $1.13B | $457.4M | $271.2M | $223.7M | $158.6M | $215.3M | $573.7M | $832.7M | $938.9M | $869.5M | $142.9M | $164.7M | $152.2M | $147.2M | $174.7M | $153.8M | $114.4M | $111.2M | $75.8M | $186.4M | ||
| Cash And Cash Equivalents At Carrying Value | $580.0M | $629.1M | $698.6M | $585.0M | $933.7M | $1.03B | $457.3M | $271.1M | $223.6M | $158.3M | $215.2M | $573.6M | $832.4M | $938.6M | $869.4M | $142.9M | $164.7M | $152.2M | $147.2M | $174.7M | $153.8M | $114.0M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $174.1M | -$4.4M | $81.8M | $81.4M | $36.5M | $9.0M | $13.2M | $3.2M | |||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | -$111.0K | $1.0M | -$2.4M | -$3.3M | -$580.0K | $553.0K | $78.0K | ||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$2.87B | -$2.77B | -$2.67B | -$2.47B | -$2.36B | -$2.26B | -$1.95B | -$1.87B | -$1.80B | -$1.52B | -$1.36B | -$1.13B | -$916.9M | -$809.4M | -$711.8M | -$512.8M | -$435.2M | -$380.5M | -$327.6M | -$314.8M | -$303.2M | -$255.7M | |||||
| Property Plant And Equipment Net | $124.6M | $126.1M | $129.3M | $125.2M | $132.3M | $138.4M | $147.7M | $155.7M | $163.2M | $168.0M | $163.4M | $151.3M | $106.2M | $89.7M | $71.8M | $61.9M | $57.0M | $46.7M | $40.8M | $34.8M | $30.6M | $30.3M | |||||
| Prepaid Expense And Other Assets Current | $42.8M | $40.0M | $35.8M | $66.9M | $87.2M | $31.7M | $26.2M | $25.8M | $33.8M | $23.6M | $28.3M | $30.1M | $22.0M | $19.2M | $15.7M | $9.9M | $11.1M | $14.1M | $5.7M | $4.1M | $6.2M | $4.0M | |||||
| Other Liabilities Noncurrent | $94.4M | $91.2M | $92.5M | $89.4M | $95.9M | $96.8M | $10.2M | $9.5M | $9.1M | $7.0M | $9.3M | $6.9M | $3.4M | $2.5M | $1.7M | $1.9M | $1.4M | $1.5M | $1.2M | $1.3M | $150.0K | $206.0K | |||||
| Other Assets Noncurrent | $41.5M | $37.2M | $32.6M | $31.3M | $29.9M | $94.2M | $128.0M | $107.7M | $59.0M | $51.7M | $70.6M | $70.9M | $61.3M | $36.3M | $17.3M | $5.5M | $5.1M | $4.7M | $3.1M | $3.2M | $2.9M | $1.9M | |||||
| Liabilities Current | $236.9M | $238.4M | $225.8M | $197.3M | $201.6M | $220.0M | $226.8M | $200.9M | $204.2M | $175.1M | $167.8M | $228.8M | $102.3M | $96.6M | $95.5M | $72.0M | $70.0M | $82.3M | $67.8M | $57.0M | $48.2M | $32.1M | |||||
| Liabilities And Stockholders Equity | $1.28B | $1.33B | $1.34B | $1.54B | $1.61B | $1.70B | $1.80B | $1.84B | $1.51B | $1.70B | $1.85B | $2.13B | $2.23B | $2.29B | $2.35B | $1.26B | $1.28B | $948.2M | $948.3M | $940.0M | $579.2M | $344.6M | |||||
| Liabilities | $1.63B | $1.64B | $1.60B | $1.60B | $1.61B | $1.64B | $1.57B | $1.55B | $1.56B | $1.54B | $1.53B | $1.60B | $1.46B | $1.44B | $1.44B | $113.5M | $112.5M | $117.6M | $86.4M | $77.7M | $64.5M | $47.5M | |||||
| Inventory Net | $90.5M | $84.1M | $77.3M | $72.3M | $67.0M | $63.0M | $77.0M | $60.5M | $46.5M | $63.0M | $59.9M | $36.6M | $24.7M | $26.5M | $28.9M | $27.7M | $20.4M | $25.1M | $14.8M | $14.2M | $10.3M | $7.1M | |||||
| Common Stock Value Outstanding | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0.00 | |||||
| Assets Current | $828.9M | $883.4M | $927.0M | $1.23B | $1.29B | $1.31B | $1.35B | $1.40B | $1.10B | $1.13B | $1.04B | $1.11B | $1.59B | $1.89B | $2.03B | $1.09B | $1.01B | $607.4M | $583.1M | $604.2M | $512.3M | $297.1M | |||||
| Assets | $1.28B | $1.33B | $1.34B | $1.54B | $1.61B | $1.70B | $1.80B | $1.84B | $1.51B | $1.70B | $1.85B | $2.13B | $2.23B | $2.29B | $2.35B | $1.26B | $1.28B | $948.2M | $948.3M | $940.0M | $579.2M | $344.6M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.3M | -$3.7M | -$4.7M | -$3.3M | -$5.6M | -$4.8M | -$5.7M | -$8.5M | -$12.2M | -$26.9M | -$24.3M | -$18.3M | -$593.0K | $33.0K | $904.0K | $3.9M | $5.4M | $7.7M | $1.1M | $1.3M | $333.0K | -$531.0K | |||||
| Accounts Receivable Net Current | $115.6M | $130.3M | $115.4M | $88.5M | $100.5M | $84.6M | $88.8M | $86.5M | $87.2M | $86.2M | $95.3M | $84.3M | $60.7M | $53.7M | $48.0M | $36.3M | $41.0M | $48.0M | $39.7M | $40.4M | $29.0M | $14.6M | |||||
| Intangible Assets Net Excluding Goodwill | $5.5M | $5.9M | $6.3M | $7.3M | $7.7M | $8.3M | $9.7M | $10.4M | $11.0M | $12.4M | $13.1M | $13.7M | $14.7M | $15.2M | $15.7M | $16.6M | $17.1M | $17.7M | $8.8M | $9.0M | |||||||
| Goodwill | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M | $2.9M | ||||||||
| Operating Lease Right Of Use Asset | $163.6M | $169.8M | $140.5M | $145.0M | $146.1M | $151.9M | $161.7M | $165.3M | $170.7M | $178.7M | $183.7M | $188.6M | $196.4M | $201.0M | $205.7M | $36.1M | $38.5M | $30.1M | |||||||||
| Accounts Payable Current | $20.1M | $44.8M | $49.8M | $15.5M | $42.4M | $37.6M | $40.9M | $37.0M | $32.2M | $17.6M | $15.7M | $21.4M | $22.3M | $18.3M | $16.0M | $24.4M | $12.1M | $15.7M | $7.2M | $13.1M | |||||||
| Operating Lease Liability Noncurrent | $185.4M | $192.3M | $160.4M | $170.1M | $172.2M | $178.9M | $192.7M | $198.2M | $204.9M | $216.2M | $221.5M | $225.4M | $216.8M | $211.8M | $210.2M | $39.7M | $41.1M | $33.8M | |||||||||
| Accrued Liabilities Current | $71.7M | $71.0M | $76.0M | $71.7M | $70.7M | $67.2M | $63.5M | $63.4M | $77.2M | $51.9M | $45.3M | $40.5M | $32.0M | $27.6M | $22.3M | $24.1M | $23.1M | $17.2M | $11.1M | $9.1M | $7.5M | ||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.0M | $3.9M | $170.8M | $2.0M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $166.2M | $140.4M | $90.8M | $94.7M | $151.4M | $144.1M | $17.0M | $6.9M | $3.7M | $2.0M |
| Proceeds From Stock Options Exercised | $19.2M | $3.1M | $405.0K | $2.6M | $8.1M | $9.5M | $11.6M | $3.1M | $753.0K | $266.0K |
| Payments To Acquire Property Plant And Equipment | $48.3M | $35.1M | $20.5M | $77.5M | $75.0M | $36.2M | $18.7M | $20.2M | $6.7M | $1.8M |
| Net Cash Provided By Used In Operating Activities | -$184.8M | -$239.9M | -$325.0M | -$309.5M | -$209.0M | -$103.9M | -$47.1M | -$72.2M | -$72.2M | -$36.7M |
| Net Cash Provided By Used In Investing Activities | -$627.2M | -$261.3M | $840.3M | $149.8M | -$63.2M | -$617.1M | -$317.6M | -$153.0M | -$170.4M | $26.2M |
| Net Cash Provided By Used In Financing Activities | $671.1M | -$996.0K | $477.4M | -$189.1M | -$66.8M | $1.41B | $367.3M | $293.2M | $281.7M | $39.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $6.4M | $7.7M | $4.3M | -$20.4M | $35.8M | $6.1M | $6.2M | $3.7M | -$30.0K | $610.0K |
| Increase Decrease In Other Operating Assets | -$212.0K | $2.4M | -$1.3M | -$11.7M | $4.2M | $19.3M | $2.9M | $451.0K | $883.0K | -$12.0K |
| Increase Decrease In Inventories | $14.8M | $9.1M | $10.4M | $20.9M | $8.0M | $7.5M | $6.0M | $1.8M | $4.5M | $351.0K |
| Increase Decrease In Accounts Receivable | $28.2M | $21.4M | -$8.4M | -$375.0K | $44.4M | $5.5M | $7.4M | $22.9M | $9.3M | $2.8M |
| Depreciation Depletion And Amortization | $39.7M | $42.4M | $42.9M | $36.0M | $22.3M | $16.1M | $11.4M | $7.1M | $5.2M | $3.7M |
| Adjustments Related To Tax Withholding For Share Based Compensation | $30.5M | $15.7M | $11.2M | $7.9M | $83.8M | $3.4M | ||||
| Payments Of Stock Issuance Costs | $17.7M | $0.00 | $21.1M | $0.00 | $0.00 | $1.1M | $723.0K | $4.4M | $0.00 | $0.00 |
| Payments Related To Tax Withholding For Share Based Compensation | $30.5M | $15.7M | $11.2M | $7.9M | $83.8M | $3.4M | $0.00 | $0.00 | ||
| Proceeds From Issuance Of Common Stock | $257.1M | $0.00 | $90.6M | $0.00 | $0.00 | $355.7M | $350.4M | $254.0M | $0.00 | |
| Increase Decrease In Operating Lease Liabilities | -$37.5M | -$36.1M | -$31.5M | -$20.2M | $14.2M | |||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $37.8M | $27.0M | $22.3M | $24.8M | $55.1M | $6.3M | $3.2M | $1.3M | |||||||||||
| Proceeds From Stock Options Exercised | $768.0K | $213.0K | $157.0K | $963.0K | $4.5M | $1.5M | $538.0K | $1.3M | |||||||||||
| Payments To Acquire Property Plant And Equipment | $4.5M | $6.9M | $7.5M | $22.7M | $9.6M | $9.6M | $2.7M | $4.0M | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$62.7M | -$30.3M | -$74.4M | -$28.6M | -$16.3M | -$13.3M | -$4.3M | -$6.6M | |||||||||||
| Net Cash Provided By Used In Investing Activities | $302.9M | $28.1M | $157.2M | $110.8M | $123.9M | $20.8M | $15.3M | $8.5M | |||||||||||
| Net Cash Provided By Used In Financing Activities | -$66.9M | -$1.1M | -$854.0K | -$12.0K | -$70.0M | $1.5M | $2.3M | $1.3M | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.1M | $5.6M | $3.4M | -$21.9M | -$521.0K | $2.6M | $947.0K | $1.3M | |||||||||||
| Increase Decrease In Other Operating Assets | -$697.0K | -$1.0M | -$1.8M | -$3.8M | -$1.2M | -$161.0K | $833.0K | -$255.0K | |||||||||||
| Increase Decrease In Inventories | $6.2M | $1.0M | -$5.1M | $5.9M | $6.2M | $10.0M | $1.1M | -$321.0K | |||||||||||
| Increase Decrease In Accounts Receivable | $6.1M | -$4.2M | -$12.3M | -$13.3M | -$5.3M | $179.0K | -$11.6M | -$623.0K | |||||||||||
| Depreciation Depletion And Amortization | $10.2M | $10.7M | $10.3M | $7.2M | $5.0M | $3.3M | $2.4M | $1.4M | |||||||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $2.3M | $7.4M | $15.5M | $2.9M | $3.2M | $1.5M | $3.0M | $4.1M | $993.0K | $4.3M | $1.2M | $957.0K | $7.2M | $1.4M | $73.6M | $2.2M | |||
| Payments Of Stock Issuance Costs | $0.00 | $89.0K | $0.00 | ||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $15.5M | $1.5M | $993.0K | $957.0K | $73.6M | $0.00 | |||||||||||||
| Proceeds From Issuance Of Common Stock | |||||||||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$9.6M | -$8.8M | -$7.4M | -$3.1M | -$2.8M | -$1.9M | $329.0K | ||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $773.0K | -$1.1M | -$163.0K | -$792.0K | -$1.1M | $23.0K | -$69.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.32 | -$3.56 | -$4.28 | -$6.41 | -$4.00 | -$2.60 | -$0.84 | -$2.80 | -$7.07 | -$3.53 |
| Weighted Average Number Of Shares Outstanding Basic | 125.4M | 122.7M | 112.0M | 102.2M | 101.3M | 97.5M | 90.6M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 125.4M | 122.7M | 112.0M | 102.2M | 101.3M | 97.5M | 90.6M | |||
| Earnings Per Share Basic | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-4.00 | $-2.60 | $-0.84 | |||
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 111.9M | |
| Common Stock Shares Outstanding | 130.6M | 124.0M | 121.6M | 102.6M | 101.8M | 100.2M | 94.3M | 85.8M | 11.9M | |
| Common Stock Shares Issued | 130.6M | 124.0M | 121.6M | 102.6M | 101.8M | 100.2M | 94.3M | 85.8M | 11.9M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.74 | -$0.80 | -$0.77 | -$0.88 | -$0.84 | -$0.94 | -$0.73 | -$0.67 | -$1.30 | -$1.58 | -$2.25 | -$1.21 | -$1.06 | -$0.96 | -$1.09 | -$0.78 | -$0.57 | -$0.29 | -$0.14 | -$0.13 | -$0.30 | -$1.94 | -$1.75 | -$1.16 | -$2.76 |
| Weighted Average Number Of Shares Outstanding Basic | 124.8M | 124.1M | 123.9M | 123.1M | 122.4M | 121.7M | 117.7M | 108.8M | 102.7M | 102.3M | 102.0M | 101.9M | 101.4M | 101.2M | 101.0M | 99.6M | 96.0M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 124.8M | 124.1M | 123.9M | 123.1M | 122.4M | 121.7M | 117.7M | 108.8M | 102.7M | 102.3M | 102.0M | 101.9M | 101.4M | 101.2M | 101.0M | 99.6M | 96.0M | ||||||||
| Earnings Per Share Basic | $-0.74 | $-0.80 | $-0.77 | $-0.88 | $-0.84 | $-0.94 | $-0.73 | $-0.67 | $-1.30 | $-1.58 | $-2.25 | $-1.21 | $-1.06 | $-0.96 | $-1.09 | $-0.78 | $-0.57 | ||||||||
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | ||||
| Common Stock Shares Outstanding | 125.0M | 124.5M | 123.6M | 123.2M | 123.0M | 121.8M | 117.8M | 117.7M | 102.7M | 102.4M | 102.2M | 101.9M | 101.6M | 101.3M | 101.1M | 99.9M | 99.3M | 94.5M | 93.9M | 92.8M | 86.1M | 13.0M | |||
| Common Stock Shares Issued | 126.0M | 125.5M | 124.6M | 123.2M | 123.0M | 121.8M | 117.8M | 117.7M | 102.7M | 102.4M | 102.2M | 101.9M | 101.6M | 101.3M | 101.1M | 99.9M | 99.3M | 94.5M | 93.9M | 92.8M | 86.1M | 13.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $166.2M | $140.4M | $90.8M | $94.7M | $151.4M | $144.1M | $17.0M | $6.9M | $3.7M | $283.0K |
| Investment Income Interest | $34.1M | $53.7M | $35.4M | $6.1M | $3.9M | $10.2M | $13.7M | $5.3M | $2.2M | $733.0K |
| Costs And Expenses | $1.42B | $1.18B | $1.13B | $993.9M | $784.7M | $541.7M | $296.7M | $183.6M | $126.5M | $69.1M |
| Stock Issued During Period Value Stock Options Exercised | $19.2M | $3.1M | $405.0K | $2.6M | $8.1M | $9.5M | $11.6M | $2.9M | $753.0K | $266.0K |
| Additional Paid In Capital | $2.90B | $2.44B | $2.30B | $1.74B | $1.66B | $1.90B | $1.15B | $764.0M | $4.9M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $13.6M | $11.7M | $10.2M | $9.3M | $9.8M | $7.1M | $6.4M | |||
| Other Noncash Income Expense | $294.0K | -$5.8M | -$1.5M | -$21.0K | -$47.0K | -$7.2M | $0.00 | $13.0K | ||
| Stock Issued During Period Shares Stock Options Exercised | 627.3K | 609.5K | 51.1K | 228.3K | 693.1K | 1.4M | 3.0M | 1.0M | 342.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $42.8M | $42.5M | $37.8M | $49.8M | $27.2M | $27.0M | $21.8M | $22.4M | $22.3M | $20.6M | $25.5M | $24.8M | $35.0M | $34.5M | $55.1M | $55.2M | $25.8M | $6.3M | $5.5M | $3.2M | $3.2M | $1.8M | $1.2M | $1.3M | |
| Investment Income Interest | $7.4M | $7.6M | $9.1M | $13.3M | $13.9M | $14.9M | $11.7M | $6.7M | $3.1M | $1.8M | $1.4M | $778.0K | $689.0K | $1.0M | $1.6M | $2.3M | $2.6M | $3.3M | $4.3M | $3.1M | $2.5M | $958.0K | $989.0K | $985.0K | $657.0K |
| Costs And Expenses | $364.2M | $338.5M | $314.5M | $308.8M | $277.9M | $268.2M | $256.6M | $256.8M | $262.8M | $262.0M | $239.5M | $219.4M | $202.1M | $189.7M | $186.5M | $148.8M | $121.0M | $102.4M | $78.3M | $69.2M | $60.3M | $45.9M | $42.1M | $35.3M | $39.8M |
| Stock Issued During Period Value Stock Options Exercised | $3.7M | $1.6M | $768.0K | $20.0K | $2.4M | $213.0K | $70.0K | $63.0K | $157.0K | $347.0K | $1.2M | $963.0K | $1.7M | $926.0K | $4.5M | $3.9M | $2.0M | $1.5M | $4.3M | $5.0M | $538.0K | $839.0K | $424.0K | $1.1M | |
| Additional Paid In Capital | $2.56B | $2.52B | $2.47B | $2.41B | $2.36B | $2.33B | $2.19B | $2.17B | $1.76B | $1.72B | $1.70B | $1.68B | $1.63B | $1.60B | $1.56B | $1.60B | $1.54B | $1.16B | $1.14B | $1.13B | $771.0M | $11.4M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $7.7M | $7.2M | $6.7M | $5.7M | $5.4M | $4.0M | $3.2M | $1.9M | |||||||||||||||||
| Other Noncash Income Expense | -$940.0K | -$1.4M | $300.0K | -$21.0K | $0.00 | -$56.0K | |||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 44.1K | 36.8K | 21.0K | 105.2K | 282.9K | 242.0K | 146.3K |
Most recent annual filing with the SEC: February 19, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.